Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy

Shiyang Wang,Yue Shi
DOI: https://doi.org/10.2147/IJN.S388604
IF: 7.033
2022-12-21
International Journal of Nanomedicine
Abstract:Shiyang Wang, Yue Shi Department of Geriatric Surgery, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China Correspondence: Yue Shi, Department of Geriatric Surgery, The First Hospital of China Medical University, Shenyang, 110001, People's Republic of China, Tel +86-13842073309, Email Exosomes are small vesicles secreted by living cells, with a typical lipid bilayer structure. They carry a variety of proteins, lipids, RNA and other important information, play an important role in the transmission of substances and information between cells, and gradually become a marker for early diagnosis of many diseases and an important tool in drug delivery system. Immune cells are an important part of tumor microenvironment, and they can affect tumor progression by secreting a variety of immunoreactive substances. This review focuses on the effects of various immune cell-derived exosomes on tumor cells, different immune cells and other stromal cells in tumor microenvironment. Exosomes derived from different immune cells can not only reshape a pro-inflammatory microenvironment to inhibit tumor progression, but also promote tumor progression by inhibiting the killing effect of NK cells, CD8 + T cells and other cells or promoting tumor cells and immunosuppressive immune cells. In addition, we also discussed that some exosomes derived from immune cells (such as DC, M1 macrophages and neutrophils) play a tumor inhibitory role after being engineered. Keywords: tumor, exosome, tumor immunity, immune cells, engineered exosomes Exosomes are 40–100nm sized vesicles released into the microenvironment by different types of cells. Exosomes contain proteins, RNA (including miRNA, LncRNA and mRNA) and lipids. They are an important medium for cell–cell interaction in the tumor microenvironment. 1 Exosomes can be secreted by a variety of cells, and exosomes from tumor cells can act on other stromal cells in the tumor microenvironment, for example, they can act on vascular endothelial cells to promote angiogenesis to provide nutrition for tumors, act on other tumor cells to promote their value-added migration ability, or act on immune cells to create an immunosuppressive microenvironment, resulting in immune escape. 2–4 The process of exosome production in various cells is similar, with cells producing small vesicles through endocytosis, which fuse to form early endosomes and gradually become late endosomes. With the entry of some "Cargo" such as cytosolic RNA, proteins, and lipids, late endosomes produce many intraluminal vesicles (ILVs) and evolve into multivesicular bodies (MVB); subsequently, these vesicles are released outside the cell to form exosomes. 1 Under different physiological and pathological conditions, their contents are often different, reflecting the physiological and pathological states of the original host cells, which makes exosomes as reliable carriers for precision medicine and liquid biopsy. 5 For most solid tumors, the traditional treatment methods include surgery, radiotherapy, chemotherapy and so on. Immunotherapy is a new treatment method in recent years. Biological immunotherapy includes several types: 1. Biological cells: such as dendritic cells (DCs) and T cells, which are immune cells in the human immune system. By enhancing the role of immune cells, they can fight against tumors; 6,7 2. Immunotherapeutic drugs: for example, immune checkpoint blocking (ICB) therapy mainly prevents immune escape by targeting PD-L1, PD-1, CTLA-4, so that immune cells, especially T cells, can play an immune killing role again. 8 Nowadays, more and more studies have found that immune cells also produce exosomes, which also play a double-edged sword role in the tumor microenvironment. It is worth noting that exosomes from T cells or NK cells produce immune killing effect on tumor cells, and exosomes have the ability to cross physical barriers, inherent targeting characteristics and their increased biocompatibility. It has great potential as a new drug delivery system, which may provide new possibilities for tumor immunotherapy. In this review, we summarized the roles and mechanisms of various immune cell-derived exosomes in the tumor microenvironment, and discussed the possible therapeutic effects of engineered immune cell-derived exosomes on tumors. The biogenesis of exosomes involves double invagination and subsequent plasma membrane fusion. First, the cell membrane buds inwards to form early endosome (EE), and then chimes with Golgi complex membrane to form late endosome (LE). LE selectively wraps some specific soluble components in cytoplasm, including nucleic acid, protein and lipid, and then forms intraluminal vesicle (ILV, precursor of exosomes). The ILV fuses with each other to form multiple intraluminal ve -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology
What problem does this paper attempt to address?